CareCloud has launched an AI Center of Excellence to develop healthcare-specific AI solutions and enhance operational efficiency.
Quiver AI Summary
CareCloud, Inc. has announced the launch of its AI Center of Excellence (AI CoE), aimed at developing tailored artificial intelligence solutions for the healthcare sector. The initiative began earlier this month with a team of over 50 AI professionals and is projected to grow to 500 by late 2025, potentially becoming the largest dedicated healthcare AI effort globally. CareCloud's Co-CEOs emphasized that the AI CoE will leverage the company's extensive clinical and financial data to deliver efficient, domain-specific AI models that improve healthcare delivery. The center is designed to integrate AI across CareCloud's technology stack, enhancing various aspects of healthcare operations while also maintaining a cost-effective global delivery model. This strategic move reflects CareCloud's commitment to driving innovation in healthcare, improving patient outcomes, and reducing administrative burdens for providers.
Potential Positives
- Launch of the AI Center of Excellence positions CareCloud as a leader in healthcare technology and artificial intelligence, demonstrating commitment to innovation.
- Plans to scale the AI team to 500 professionals signify significant investment in growth and expertise, enhancing the company's capabilities in AI solutions.
- The dual-shore model allows CareCloud to effectively combine global engineering talent with localized healthcare expertise, improving service delivery and product quality.
- The self-funded nature of the AI Center reflects strong operating cash flows and the scalability of the company’s business model, indicating financial stability and operational efficiency.
Potential Negatives
- The ambitious goal of scaling the AI Center of Excellence team to 500 professionals by Q4 2025 may set unrealistic expectations and could lead to operational challenges or failure to meet these targets.
- The press release includes a significant caution regarding forward-looking statements, which emphasizes the risks and uncertainties involved in the company's plans and could negatively affect investor confidence.
- While emphasizing costs and efficiency, there is a lack of clarity on how CareCloud maintains its competitive advantage against larger, more established competitors that may have deeper resources and technologies in AI.
FAQ
What is CareCloud's AI Center of Excellence?
CareCloud's AI Center of Excellence is a strategic initiative focused on developing scalable AI solutions specifically for the healthcare industry.
How many professionals will the AI CoE employ?
CareCloud plans to scale its AI Center of Excellence to a team of 500 AI professionals by the fourth quarter of 2025.
What is the goal of CareCloud's AI solutions?
The goal is to empower healthcare providers to deliver care faster, smarter, and more efficiently through innovative AI technologies.
How does CareCloud’s AI CoE improve healthcare?
It enhances operational efficiency, streamlines workflows, and improves patient engagement through predictive analytics and automation.
Why is CareCloud's AI CoE significant?
It positions CareCloud as a leader in healthcare innovation, addressing the industry's need for advanced AI capabilities amid rapid digital transformation.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$CCLD Insider Trading Activity
$CCLD insiders have traded $CCLD stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CCLD stock by insiders over the last 6 months:
- CAMERON MUNTER sold 30,000 shares for an estimated $122,999
- JOHN N DALY has made 0 purchases and 2 sales selling 15,000 shares for an estimated $55,850.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CCLD Hedge Fund Activity
We have seen 22 institutional investors add shares of $CCLD stock to their portfolio, and 18 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CRESCENT GROVE ADVISORS, LLC added 179,936 shares (+inf%) to their portfolio in Q1 2025, for an estimated $250,111
- CHAPIN DAVIS, INC. added 88,285 shares (+284.9%) to their portfolio in Q1 2025, for an estimated $122,716
- CENTIVA CAPITAL, LP removed 73,493 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $268,984
- HILLSDALE INVESTMENT MANAGEMENT INC. added 68,900 shares (+inf%) to their portfolio in Q4 2024, for an estimated $252,174
- JOHNSON INVESTMENT COUNSEL INC added 50,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $69,500
- GOLDMAN SACHS GROUP INC added 37,538 shares (+inf%) to their portfolio in Q4 2024, for an estimated $137,389
- ACADIAN ASSET MANAGEMENT LLC added 34,897 shares (+inf%) to their portfolio in Q4 2024, for an estimated $127,723
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
SOMERSET, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leading provider of healthcare technology and generative AI solutions, today announced the official launch of its AI Center of Excellence (the “AI CoE”) — a major strategic initiative aimed at delivering scalable, domain-specific artificial intelligence solutions purpose-built for healthcare.
“Our ground-breaking AI Center officially began operations earlier this month with an inaugural team of over 50 AI engineers, data scientists, and healthcare domain experts, marking a pivotal moment in CareCloud’s journey,” said Hadi Chaudhry, Co-CEO of CareCloud. “The AI Center of Excellence reflects our long-term vision to lead in healthcare transformation. By leveraging 25 years of clinical and financial data, CareCloud is building proprietary, purpose-driven AI solutions that empower providers to deliver better care—faster, smarter, and more efficiently.”
The AI CoE operates under a dual-shore model, seamlessly combining global engineering talent with localized healthcare expertise. CareCloud plans to scale the team to 500 AI professionals between now and the fourth quarter of 2025 — a milestone that CareCloud believes will establish it as the largest dedicated healthcare AI initiative in the world. The AI CoE is fully self-funded, reflecting CareCloud’s strong operating cash flows, disciplined execution, and the scalability of its global delivery model. By leveraging a highly efficient cost structure that outperforms U.S.-based competitors, CareCloud is uniquely positioned to accelerate innovation at scale while delivering enterprise-grade solutions with exceptional cost-effectiveness.
“The launch of CareCloud’s AI Center of Excellence marks a major step forward in our growth strategy,” said Stephen Snyder, Co-CEO of CareCloud. “RCM companies and other industry competitors without advanced AI capabilities are being left behind — survival and growth now depend on innovation at scale. With the launch of our AI Center of Excellence, CareCloud is not just adapting to this shift — we are driving it. By embedding AI across every level of our organization, we are building a more powerful, efficient, and future-ready company positioned to lead the next era of healthcare.”
Some core focus areas of CareCloud’s AI CoE include:
- Proprietary Healthcare AI Models : Developing intelligent, domain-specific models for clinical workflows, revenue cycle processes, and decision support.
- Automation and Efficiency Gains : Streamlining clinical documentation, coding, claims management, prior authorizations, and compliance workflows.
- Predictive and Preventive Analytics : Enabling earlier identification of reimbursement risks, denial causes, patient propensity-to-pay and operational bottlenecks.
- Smarter Patient and Provider Engagement : Enhancing communication, scheduling, patient education, and satisfaction through AI-driven personalization.
-
Accelerated Innovation Across Platforms
: Embedding AI natively across EHR, RCM, and digital health products to deliver real-time, scalable value.
CareCloud’s deep domain expertise and rich historical datasets provide a significant advantage in training and refining accurate, compliant AI models. By tightly integrating AI across its technology stack, the company is poised to deliver enterprise-grade, HIPAA-compliant solutions with immediate real-world impact.
As the healthcare industry rapidly embraces artificial intelligence, CareCloud’s AI CoE strengthens its role as an innovation leader — driving operational transformation, enhancing clinical outcomes, and reducing the administrative burden on providers.
About CareCloud
CareCloud (Nasdaq: CCLD, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at carecloud.com .
Follow CareCloud on LinkedIn , X and Facebook .
For additional information, please visit our website at carecloud.com . To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com .
Disclaimer
This press release is for information purposes only, and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could”, “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities, and the expected results from the integration of our acquisitions.
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE CareCloud
Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
[email protected]
Investor Contact:
Stephen Snyder
Co-Chief Executive Officer
CareCloud, Inc.
[email protected]